Cabaletta Bio (CABA) Short Interest Ratio & Short Volume → Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad) Free CABA Stock Alerts $10.54 -0.48 (-4.36%) (As of 08:34 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cabaletta Bio Short Interest DataCurrent Short Interest9,100,000 sharesPrevious Short Interest10,250,000 sharesChange Vs. Previous Month-11.22%Dollar Volume Sold Short$115.48 millionShort Interest Ratio8.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares48,280,000 sharesPercentage of Shares Shorted18.85%Today's Trading Volume158 sharesAverage Trading Volume1,021,504 sharesToday's Volume Vs. Average0% Short Selling Cabaletta Bio ? Sign up to receive the latest short interest report for Cabaletta Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCABA Short Interest Over TimeCABA Days to Cover Over TimeCABA Percentage of Float Shorted Over Time Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Cabaletta Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20249,100,000 shares $115.48 million -11.2%N/A8.1 $12.69 4/30/202410,250,000 shares $109.11 million +3.9%N/A8.9 $10.65 4/15/20249,870,000 shares $159.70 million +16.1%N/A10.3 $16.18 3/31/20248,500,000 shares $145.01 million +19.9%N/A9 $17.06 3/15/20247,090,000 shares $132.87 million +1.1%N/A7.9 $18.74 2/29/20247,010,000 shares $160.39 million +2.6%N/A7.1 $22.88 Get the Latest News and Ratings for CABA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cabaletta Bio and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,830,000 shares $163.24 million +6.9%N/A5.4 $23.90 1/31/20246,390,000 shares $130.87 million -0.5%N/A5 $20.48 1/15/20246,420,000 shares $136.10 million +3.2%N/A5.4 $21.20 12/31/20236,220,000 shares $141.19 million +10.5%N/A5.3 $22.70 12/15/20235,630,000 shares $115.70 million -0.7%N/A4.8 $20.55 11/30/20235,670,000 shares $91.00 million +12.1%N/A4.9 $16.05 11/15/20235,060,000 shares $87.89 million -19.4%N/A6.4 $17.37 10/31/20236,280,000 shares $89.55 million +1.5%N/A8.6 $14.26 10/15/20236,190,000 shares $94.83 million +19.3%N/A9.1 $15.32 9/30/20235,190,000 shares $78.99 million +65.3%N/A8 $15.22 9/15/20233,140,000 shares $49.64 million -3.7%N/A5 $15.81 8/31/20233,260,000 shares $46.16 million -39.2%N/A6 $14.16 8/15/20235,360,000 shares $73.27 million +6.1%N/A11.6 $13.67 7/31/20235,050,000 shares $68.78 million -8.4%N/A10.4 $13.62 7/15/20235,510,000 shares $66.73 million +4.8%N/A11 $12.11 6/30/20235,260,000 shares $67.91 million +22.3%N/A11.2 $12.91 6/15/20234,300,000 shares $55.34 million +7.0%N/A9.9 $12.87 5/31/20234,020,000 shares $40.56 million +1.0%N/A11.8 $10.09 5/15/20233,980,000 shares $45.69 million -0.5%N/A11 $11.48 4/30/20234,000,000 shares $41.52 million -1.0%N/A10.3 $10.38 4/15/20234,040,000 shares $31.55 million +9.8%N/A9.3 $7.81 3/31/20233,680,000 shares $30.43 million +3.1%N/A7.2 $8.27 3/15/20233,570,000 shares $26.45 million +2.6%N/A5.5 $7.41 2/28/20233,480,000 shares $30.76 million +3.0%N/A4.6 $8.84 2/15/20233,380,000 shares $27.21 million -0.3%N/A4.2 $8.05 1/31/20233,390,000 shares $41.32 million +3.7%N/A3.9 $12.19 1/15/20233,270,000 shares $32.77 million -7.4%N/A2.6 $10.02 12/30/20223,530,000 shares $32.65 million -0.3%N/A2.6 $9.25 12/15/20223,540,000 shares $23.90 million -3.5%N/A2.7 $6.75 11/30/20223,670,000 shares $16.44 million +6.4%N/A2.8 $4.48 11/15/20223,450,000 shares $12.32 million -8.5%N/A2.3 $3.57 10/31/20223,770,000 shares $6.37 million +5.9%N/A1.9 $1.69 10/15/20223,560,000 shares $3.03 million -23.6%N/A1.8 $0.85 9/30/20224,660,000 shares $3.03 million +11.8%N/A3.5 $0.65Executive Order To Wipe Out Your Bank Accounts (Ad)Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! 9/15/20224,170,000 shares $3.67 million +21.2%N/A3.2 $0.88 8/31/20223,440,000 shares $3.28 million +55.0%N/A2.8 $0.95 8/15/20222,220,000 shares $3.40 million +8.3%N/A2.4 $1.53 7/31/20222,050,000 shares $2.42 million +4.6%N/A11.3 $1.18 7/15/20221,960,000 shares $3.04 million +6.5%N/A12.2 $1.55 6/30/20221,840,000 shares $1.95 million +0.6%N/A11.4 $1.06 6/15/20221,830,000 shares $1.83 million +1.7%N/A12.2 $1.00 5/31/20221,800,000 shares $2.30 million -1.6%N/A11.2 $1.28 5/15/20221,830,000 shares $2.73 million +2.8%N/A10.3 $1.49 4/30/20221,780,000 shares $2.46 million No ChangeN/A10.1 $1.38 4/15/20221,780,000 shares $3.24 million -2.2%N/A10 $1.82 3/31/20221,820,000 shares $3.69 million No ChangeN/A11 $2.03 3/15/20221,820,000 shares $3.06 million +2.8%N/A8.7 $1.68 2/28/20221,770,000 shares $3.82 million No ChangeN/A3 $2.16 2/15/20221,770,000 shares $5.01 million -0.6%N/A3.1 $2.83 1/31/20221,780,000 shares $5.38 million -1.1%N/A3 $3.02 1/15/20221,800,000 shares $6.17 million -1.1%N/A3 $3.43 12/31/20211,820,000 shares $6.90 million -1.1%N/A3 $3.79 12/15/20211,840,000 shares $7.30 million +1.1%N/A3.1 $3.97 11/30/20211,820,000 shares $21.08 million +10.3%N/A11.1 $11.58 11/15/20211,650,000 shares $19.93 million +22.2%N/A8.1 $12.08 10/29/20211,350,000 shares $18.45 million No ChangeN/A7 $13.67 10/15/20211,350,000 shares $16.55 million No Change8.7%8 $12.26 9/30/20211,350,000 shares $16.42 million +0.8%8.7%9.1 $12.16 9/15/20211,340,000 shares $15.54 million +1.5%8.7%8.2 $11.60 8/31/20211,320,000 shares $13.44 million +0.8%8.9%8.2 $10.18 8/13/20211,310,000 shares $9.77 million -1.5%8.8%11.2 $7.46 7/30/20211,330,000 shares $9.92 million -1.5%8.4%11.4 $7.46 7/15/20211,350,000 shares $10.14 million -1.5%8.5%10.5 $7.51 6/30/20211,370,000 shares $11.78 million -11.6%8.7%10 $8.60 6/15/20211,550,000 shares $12.21 million +1.3%9.8%14.3 $7.88 5/28/20211,530,000 shares $17.35 million -6.1%9.7%15.1 $11.34 5/14/20211,630,000 shares $14.31 million -4.7%12.0%14.9 $8.78 4/30/20211,710,000 shares $19.49 million +1.2%10.4%15.6 $11.40 4/15/20211,690,000 shares $19.01 million -2.9%9.5%15.5 $11.25 3/31/20211,740,000 shares $18.32 million +1.2%9.8%15.9 $10.53 3/15/20211,720,000 shares $20.49 million +5.5%9.7%14.3 $11.91 2/26/20211,630,000 shares $18.17 million +1.2%9.2%13.5 $11.15 2/12/20211,610,000 shares $20.13 million +4.6%9.1%14.9 $12.50 1/29/20211,540,000 shares $19.33 million +4.8%8.7%15.2 $12.55 1/15/20211,470,000 shares $20.02 million +2.8%8.3%15.2 $13.62 12/31/20201,430,000 shares $17.52 million +5.2%8.3%15.9 $12.25 12/15/20201,360,000 shares $20.20 million +4.6%7.8%17.7 $14.85 11/30/20201,300,000 shares $19.54 million +7.4%7.6%18.4 $15.03 11/15/20201,210,000 shares $16.95 million +0.8%7.1%16.4 $14.01 10/30/20201,200,000 shares $14.66 million +2.6%7.1%16 $12.22 10/15/20201,170,000 shares $12.83 million +7.3%6.9%14.2 $10.97 9/30/20201,090,000 shares $11.82 million +11.0%6.4%11.4 $10.84 9/15/2020981,800 shares $11.39 million +4.5%5.8%6.1 $11.60 8/31/2020939,400 shares $9.91 million +4.0%5.5%6.1 $10.55Executive Order To Wipe Out Your Bank Accounts (Ad)Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! 8/14/2020903,300 shares $10.30 million -21.5%5.3%5.6 $11.40 7/31/20201,150,000 shares $13.14 million +26.6%6.8%6.9 $11.43 7/15/2020908,200 shares $9.96 million -26.8%7.3%5.3 $10.97 6/30/20201,240,000 shares $13.81 million +348.8%9.9%7.6 $11.14 6/15/2020276,300 shares $2.16 million +132.0%2.2%2.8 $7.81 5/29/2020119,100 shares $990,912.00 +21.7%1.0%1.2 $8.32 5/15/202097,900 shares $690,195.00 -19.0%0.8%1.2 $7.05 4/30/2020120,900 shares $876,525.00 +47.3%1.0%1.7 $7.25 4/15/202082,100 shares $569,774.00 +0.4%0.5%1.3 $6.94 3/31/202081,800 shares $522,702.00 -18.9%0.5%1.3 $6.39 3/13/2020100,800 shares $753,984.00 +21.6%0.6%3.7 $7.48 2/28/202082,900 shares $590,248.00 -4.7%0.5%1 $7.12 2/14/202087,000 shares $1.10 million -8.3%0.5%1 $12.66 1/31/202094,900 shares $1.56 million -39.3%0.6%1 $16.44 1/15/2020156,300 shares $2.41 million +0.5%0.9%1.2 $15.42 12/31/2019155,600 shares $2.72 million No Change1.1%1.2 $17.47 CABA Short Interest - Frequently Asked Questions What is Cabaletta Bio's current short interest? Short interest is the volume of Cabaletta Bio shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 9,100,000 shares of CABA short. Learn More on Cabaletta Bio's current short interest. What is a good short interest ratio for Cabaletta Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CABA shares currently have a short interest ratio of 8.0. Learn More on Cabaletta Bio's short interest ratio. Which institutional investors are shorting Cabaletta Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cabaletta Bio: Ikarian Capital LLC, StemPoint Capital LP, HAP Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cabaletta Bio's short interest increasing or decreasing? Cabaletta Bio saw a decline in short interest in May. As of May 15th, there was short interest totaling 9,100,000 shares, a decline of 11.2% from the previous total of 10,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cabaletta Bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cabaletta Bio: OPKO Health, Inc. (26.01%), Fusion Pharmaceuticals Inc. (3.60%), Sana Biotechnology, Inc. (21.23%), Neumora Therapeutics, Inc. (11.63%), Vir Biotechnology, Inc. (6.99%), BioCryst Pharmaceuticals, Inc. (16.64%), Cullinan Therapeutics, Inc. (11.90%), 4D Molecular Therapeutics, Inc. (18.67%), Tarsus Pharmaceuticals, Inc. (19.77%), Ginkgo Bioworks Holdings, Inc. (19.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Cabaletta Bio stock? Short selling CABA is an investing strategy that aims to generate trading profit from Cabaletta Bio as its price is falling. CABA shares are trading down $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cabaletta Bio? A short squeeze for Cabaletta Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CABA, which in turn drives the price of the stock up even further. How often is Cabaletta Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CABA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OPKO Health Short Interest Data Fusion Pharmaceuticals Short Interest Data Sana Biotechnology Short Interest Data Neumora Therapeutics Short Interest Data Vir Biotechnology Short Interest Data BioCryst Pharmaceuticals Short Interest Data Cullinan Therapeutics Short Interest Data 4D Molecular Therapeutics Short Interest Data Tarsus Pharmaceuticals Short Interest Data Ginkgo Bioworks Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CABA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.